Cargando…
OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine
An intramuscular formulation of onabotulinumtoxinA (onabotA; Botox(®)) is currently the only therapy specifically approved for the prevention of headaches in adults with chronic migraine (CM) in the EU and North America. This article provides a narrative review of relevant data on the drug in this i...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915521/ https://www.ncbi.nlm.nih.gov/pubmed/29532439 http://dx.doi.org/10.1007/s40265-018-0894-6 |